Vaccine-preventable infections in Systemic Lupus Erythematosus

References

• Muñoz LE, Janko C, Schulze C, Schorn C, Sarter K, Schett G, Herrmann M. Autoimmunity and chronic inflammation - two clearance-related steps in the etiopathogenesis of SLE. Autoimmun Rev. 2010; 10:38-42; http://dx.doi.org/10.1016/j.autrev.2010.08.015
   PubMed Web of Science ®Google Scholar
• Abu-Shakra M, Press J, Buskila D, Sukenik S. Influenza vaccination of patients with systemic lupus erythematosus: safety and immunogenecity issues. Autoimmun Rev 2007; 6:543-6; PMID:17854746; http://dx.doi.org/10.1016/j.autrev.2006.12.004
   PubMed Web of Science ®Google Scholar
• Zandman-Goddard G, Shoenfeld Y. Infections and SLE. Autoimmunity 2005; 38:473-85
   Google Scholar
• Petri M, Genovese M. Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of the Hopkins Lupus Cohort. J Rheumatol 1992; 19:1559-65
   PubMed Web of Science ®Google Scholar
• Zonana-Nacach A, Camargo-Coronel A, Yañez P, Sánchez L, Jimenez-Balderas FJ, Fraga A. Infections in outpatients with systemic lupus erythematosus: a prospective study. Lupus 2001; 10:505-10; http://dx.doi.org/10.1191/096120301678416088
   PubMed Web of Science ®Google Scholar
• Al Sawah S, Zhang X, Zhu B, Magder LS, Foster SA, Iikuni N, Petri M. Effect of corticosteroid use by dose on the risk of developing organ damage over time in systemic lupus erythematosus-the Hopkins Lupus Cohort. Lupus Sci Med. 2015; 2:e00006; http://dx.doi.org/10.1136/lupus-2014-000066
   Google Scholar
• Bernatsky S, Hudson M, Suissa S. Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis. Rheumatology 2007; 46:1157-60; PMID:17478469; http://dx.doi.org/10.1093/rheumatology/kem076
   PubMed Web of Science ®Google Scholar
• Glück T, Kiefmann B, Grohmann M, Falk W, Straub RH, Schölmerich J. Immune status and risk for infection in patients receiving chronic immunosuppressive therapy. J Rheumatol 2005; 32:1473-80; PMID:16078322
   PubMed Web of Science ®Google Scholar
• Allison AC. Immunosuppressive drugs: the first 50 years and a glance forward. Immunopharmacology 2000; 47:63-83; PMID:10878284; http://dx.doi.org/10.1016/S0162-3109(00)00186-7
   PubMed Web of Science ®Google Scholar
• Murdaca G, Colombo BM, Puppo F. Emerging biological drugs: a new therapeutic approach for Systemic Lupus Erythematosus. An update upon efficacy and adverse events. Autoimmun Rev 2011; 11:56-60; PMID:21835271; http://dx.doi.org/10.1016/j.autrev.2011.07.006
   PubMed Web of Science ®Google Scholar
• Murdaca G, Colombo BM, Cagnati P, Gulli R, Span∫ F, Puppo F. Update upon efficacy and safety of TNF-α inhibitors. Expert Opin Drug Saf 2012; 11:1-5; PMID:22010813; http://dx.doi.org/10.1517/14740338.2012.630388
   PubMed Web of Science ®Google Scholar
• Murdaca G, Colombo BM, Puppo F. Adalimumab for the treatment of immune-mediated diseases: an update on old and recent indications. Drugs Today (Barc) 2011; 47:277-88; PMID:21573251; http://dx.doi.org/10.1358/dot.2011.47.4.1576692
   PubMed Web of Science ®Google Scholar
• Murdaca G, Colombo BM, Puppo F. Anti-TNF-α inhibitors: a new therapeutic approach for inflammatory immune-mediated diseases: an update upon efficacy and adverse events. Int J Immunopathol Pharmacol 2009; 22:557-65; PMID:19822072
   PubMed Web of Science ®Google Scholar
• Murdaca G, Colombo BM, Barabino G, Caiti M, Cagnati P, Puppo F. Anti-tumor necrosis factor-α treatment with infliximab for disseminated granuloma annulare. Am J Clin Dermatol 2010; 11:437-9; PMID:20515080; http://dx.doi.org/10.2165/11311040-000000000-00000
   PubMed Web of Science ®Google Scholar
• Puppo F, Murdaca G, Ghio M, Indiveri F. Emerging biologic drugs for the treatment of rheumatoid arthritis. Autoimmun Rev 2005; 4:537-41; PMID:16214092; http://dx.doi.org/10.1016/j.autrev.2005.04.016
   PubMed Web of Science ®Google Scholar
• Sebastiani GD, Galeazzi M. Infection–genetics relationship in systemic lupus erythematosus. Lupus 2009; 18:1169-75; PMID:19880563; http://dx.doi.org/10.1177/0961203309345737
   PubMed Web of Science ®Google Scholar
• Van Ghelue M, Moens U, Bendiksen S, Rekvig OP. Autoimmunity to nucleosomes related to viral infection: a focus on hapten-carrier complex formation. J Autoimmun 2003; 20:171-82; PMID:12657530; http://dx.doi.org/10.1016/S0896-8411(02)00110-5
   PubMed Web of Science ®Google Scholar
• Piliero P, Furie R. Functional asplenia in systemic lupus erythematosus. Semin Arthritis Rheum 1990; 20:185-9; PMID:2287943; http://dx.doi.org/10.1016/0049-0172(90)90059-O
   PubMed Web of Science ®Google Scholar
• Chen CH, Tai SB, Chen HC, Yang DH, Peng MY, Lin YF. Analysis of Erythrocyte C4d to Complement Receptor 1 Ratio: Use in Distinguishing between Infection and Flare-Up in Febrile Patients with Systemic Lupus Erythematosus. Biomed Res Int 2015; 2015:939783; PMID:26273660
   PubMedGoogle Scholar
• Panda AK, Parida JR, Tripathy R, Pattanaik SS, Ravindran B, Das BK. Mannose binding lectin: a biomarker of systemic lupus erythematosus disease activity. Arthritis Res Ther 2012; 14:R218; PMID:23068019; http://dx.doi.org/10.1186/ar4057
   PubMedGoogle Scholar
• Tsai YC, Yeh KW, Yao TC, Huang YL, Kuo ML, Huang JL. Mannose-binding lectin expression genotype in pediatric-onset systemic lupus erythematosus: associations with susceptibility to renal disease and protection against infections. J Rheumatol 2011; 38:1429-35; PMID:21532056; http://dx.doi.org/10.3899/jrheum.100961
   PubMed Web of Science ®Google Scholar
• Sturfelt G, Truedsson L. Complement and its breakdown products in SLE. Rheumatology (Oxford) 2005; 44:1227-32; PMID:15972354; http://dx.doi.org/10.1093/rheumatology/keh719
   PubMed Web of Science ®Google Scholar
• Petri M. Infection in systemic lupus erythematosus. Rheum Dis Clin North Am 1998; 24:423-56; PMID:9606766; http://dx.doi.org/10.1016/S0889-857X(05)70016-8
   PubMed Web of Science ®Google Scholar
• Wadee S, Tikly M, Hopley M. Causes and predictors of death in South Africans with systemic lupus erythematosus. Rheumatology (Oxford) 2007; 46:1487-91; PMID:17681980; http://dx.doi.org/10.1093/rheumatology/kem180
   PubMed Web of Science ®Google Scholar
• Pons-Estel BA, Catoggio LJ, Cardiel MH, Soriano ER, Gentiletti S, Villa AR, Abadi I, Caeiro F, Alvarellos A, Alarcón-Segovia D. et al. The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among “Hispanics.” Medicine (Baltimore) 2004; 83:1-17; PMID:14747764; http://dx.doi.org/10.1097/01.md.0000104742.42401.e2
   PubMed Web of Science ®Google Scholar
• Houman MH, Smiti-Khanfir M, Ben Ghorbell I, Miled M. Systemic lupus erythematosus in Tunisia: demographic and clinical analysis of 100 patients. Lupus 2004; 13:204-11; PMID:15119551; http://dx.doi.org/10.1191/0961203303lu530xx
   PubMed Web of Science ®Google Scholar
• Yurkovich M1, Vostretsova K, Chen W, Aviña-Zubieta JA. Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies. Arthritis Care Res (Hoboken) 2014; 66:608-16; PMID:24106157; http://dx.doi.org/10.1002/acr.22173
   PubMed Web of Science ®Google Scholar
• Fei Y, Shi X, Gan F, Li X, Zhang W, Li M, Hou Y, Zhang X, Zhao Y, Zeng X, Zhang F. Death causes and pathogens analysis of systemic lupus erythematosus during the past 26 years. Clin Rheumatol. 2014; 33:57-63; PMID:24046218; http://dx.doi.org/10.1007/s10067-013-2383-3
   PubMed Web of Science ®Google Scholar
• Barber C, Gold WL, Fortin PR. Infections in the lupus patient: perspectives on prevention. Curr Opin Rheumatol 2011; 23:358-65; PMID:21532484; http://dx.doi.org/10.1097/BOR.0b013e3283476cd8
   PubMed Web of Science ®Google Scholar
• van Assen S, Elkayam O, Agmon-Levin N, Cervera R, Doran MF, Dougados M, Emery P, Ioannidis JP, Jayne DR, et al. Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases. Autoimmun Rev 2011; 10:341-52
   PubMed Web of Science ®Google Scholar
• Bijl M, Agmon-Levin N, Dayer JM, Israeli E, Gatto M, Shoenfeld Y. Vaccination of patients with auto-immune inflammatory rheumatic diseases requires careful benefit-risk assessment. Autoimmun Rev 2012; 11:572-6; PMID:22037116; http://dx.doi.org/10.1016/j.autrev.2011.10.015
   PubMed Web of Science ®Google Scholar
• Glück T, Müller-Ladner U. Vaccination in patients with chronic rheumatic or autoimmune diseases. Clin Infect Dis 2008; 46:1459-65; PMID:18419456; http://dx.doi.org/10.1086/587063
   PubMed Web of Science ®Google Scholar
• Naveau C, Houssiau FA. Pneumococcal sepsis in patients with systemic lupus erythematosus. Lupus 2005; 14:903-6; PMID:16335583; http://dx.doi.org/10.1191/0961203305lu2242xx
   PubMed Web of Science ®Google Scholar
• Goldblatt F, Yuste J, Isenberg DA, Rahman A, Brown J. Impaired C3b/iC3b deposition on Streptococcus pneumoniae in serum from patients with systemic lupus erythematosus. Rheumatology (Oxford) 2009; 48:1498-501; http://dx.doi.org/10.1093/rheumatology/kep289
   PubMed Web of Science ®Google Scholar
• Yee AM, Ng SC, Sobel RE, Salmon JE. Fc gammaRIIA polymorphism as a risk factor for invasive pneumococcal infections in systemic lupus erythematosus. Arthritis Rheum 1997; 40:1180-2; PMID:9385723; http://dx.doi.org/10.1002/art.1780400626
   PubMed Web of Science ®Google Scholar
• Garred P, Madsen HO, Halberg P, Petersen J, Kronborg G, Svejgaard A, Andersen V, Jacobsen S. Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Arthritis Rheum 1999; 42:2145-52; http://dx.doi.org/10.1002/1529-0131(199910)42:10%3c2145::AID-ANR15%3e3.0.CO;2-
   PubMed Web of Science ®Google Scholar
• Weinberger DM, Harboe ZB, Sanders E, Ndiritu M, Klugman KP, Rückinger S, Dagan R, Adegbola R, Cutts F, Johnson HL, et al. Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis 2010; 51:692-9; PMID:20715907; http://dx.doi.org/10.1086/655828
   PubMed Web of Science ®Google Scholar
• Vila-Córcoles A. Vaccinate your child and save its grandparents from a heart attack? Current perspectives in antipneumococcal vaccination. J Intern Med 2009; 266:432-44; http://dx.doi.org/10.1111/j.1365-2796.2009.02149.x
   PubMed Web of Science ®Google Scholar
• Fedson DS, Musher DM. Pneumococcal polysaccharide vaccine. In: Vaccines (4th Edition), Plotkin SA, Orenstein WA, eds. PA: Elsevier, 2004, 529-588.
   Google Scholar
• Centers for Disease Control and Prevention. Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children. MMWR Morb Mortal Wkly Rep 2010; 59:258-61
   PubMedGoogle Scholar
• Tan TQ. Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines. Clin Microbiol Rev 2012; 25:409-19; PMID:22763632; http://dx.doi.org/10.1128/CMR.00018-12
   PubMed Web of Science ®Google Scholar
• European Medicine Agency (EMA). Synflorix - Summary of product characteristics. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000973/WC500054346.pdf
   Google Scholar
• De Roux Schmidt N, Rose M, Zielen S, Pletz M, Lode H. Immunogenicity of the pneumococcal polysaccharide vaccine in COPD patients: the effect of systemic steroids. Respir Med 2004; 98:1187-94; PMID:15588039; http://dx.doi.org/10.1016/j.rmed.2004.04.012
   PubMed Web of Science ®Google Scholar
• Luijten RK, Cuppen BV, Bijlsma JW, Derksen RH. Serious infections in systemic lupus erythematosus with a focus on pneumococcal infections. Lupus 2014; 23:1512-6; PMID:25078055; http://dx.doi.org/10.1177/0961203314543918
   PubMed Web of Science ®Google Scholar
• Pisoni C, Sarano J, Benchetrit G, Rodríguez D, Suárez L, Perrota C, Manni J. Antipneumococcal vaccination in patient with systemic lupus erythematosus. Medicina (B.Ayres) 2003; 63:388-92
   PubMed Web of Science ®Google Scholar
• McDonald E, Jarrett MP, Schiffman G, Grayzel AI. Persistence of pneumococcal antibodies after immunization in patients with systemic lupus erythematosus. J Rheumatol 1984; 11:306-8; PMID:6737372
   PubMed Web of Science ®Google Scholar
• Battafarano DF, Battafarano NJ, Larsen L, Dyer PD, Older SA, Muehlbauer S, Hoyt A, Lima J, Goodman D, Lieberman M, et al. Antigen-specific antibody responses in lupus patients following immunization. Arthritis Rheum 1998; 41:1828-34; PMID:9778224; http://dx.doi.org/10.1002/1529-0131(199810)41:10%3c1828::AID-ART15%3e3.0.CO;2-T
   PubMed Web of Science ®Google Scholar
• Meisel R, Kuypers L, Dirksen U, Schubert R, Gruhn B, Strauss G, Beutel K, Groll AH, Duffner U, Blütters-Sawatzki R, et al. Impfung von Kindern nach allogener Stammzelltransplantation (IKAST) Study Group. Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell transplantation. Blood 2007; 109:2322-6; PMID:17090650; http://dx.doi.org/10.1182/blood-2006-06-032284
   PubMed Web of Science ®Google Scholar
• Tan LK, Carlone GM, Borrow R. Advances in the development of vaccines against Neisseria meningitidis. N Engl J Med 2010; 362:1511-20; PMID:20410516; http://dx.doi.org/10.1056/NEJMra0906357
   PubMed Web of Science ®Google Scholar
• Mitchell SR, Nguyen PQ, Katz P. Increased risk of neisseria infections in systemic lupus erythematosus. Semin Arthritis Rheum 1990; 20:174-84; PMID:2287942; http://dx.doi.org/10.1016/0049-0172(90)90058-N
   PubMed Web of Science ®Google Scholar
• Frank MM, Hamburger MI, Lawley TJ, Kimberly RP, Plotz PH. Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus. N Engl J Med 1979; 300:518-23; PMID:763252; http://dx.doi.org/10.1056/NEJM197903083001002
   PubMed Web of Science ®Google Scholar
• Lehman T, Bernstein B, Hanson V, Kornreich H, King K. Meningococcal infection complicating systemic lupus erythematosus. J Pediatr 1981; 99:94-6; PMID:6166736; http://dx.doi.org/10.1016/S0022-3476(81)80966-3
   PubMed Web of Science ®Google Scholar
• Schenfeld L, Gray RG, Poppo MJ, Gaylis NB, Gottlieb NL. Bacterial monoarthritis due to Neisseria meningitidis in systemic lupus erythematosus. J Rheumatol 1981; 8:145-8; PMID:7218243
   PubMed Web of Science ®Google Scholar
• Feliciano R, Swedler W, Varga J. Infection with uncommon subgroup Y Neisseria meningitidis in patients with systemic lupus erythematosus. Clin Exp Rheumatol 1999; 17:737-40; PMID:10609076
   PubMed Web of Science ®Google Scholar
• Zenone T, Sartre J, Gibert C, Gallen-Labbé F. Infection with Neisseria meningitidis serogroup Y revealing systemic lupus erythematosus. Lupus. 2010; 19:1676-8; PMID:20667940; http://dx.doi.org/10.1177/0961203310376954
   PubMed Web of Science ®Google Scholar
• Schenfeld L, Gray RG, Poppo MJ, Gaylis NB, Gottlieb NL. Bacterial monarthritis due to Neisseria meningitidis in systemic lupus erythematosus. J Rheumatol 1981; 8:145-8; PMID:7218243
   PubMed Web of Science ®Google Scholar
• Meningococcal vaccines: WHO position paper, November 2011. Wkly Epidemiol Rec 2011; 86:521-39; PMID:22128384
   PubMedGoogle Scholar
• Granoff DM, Gupta RK, Belshe RB, Anderson EL. Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination. J Infect Dis 1998; 178:870-4; PMID:9728562; http://dx.doi.org/10.1086/515346
   PubMed Web of Science ®Google Scholar
• Girard MP, Preziosi MP, Aguado MT, Kieny MP. A review of vaccine research and development: meningococcal disease. Vaccine 2006; 24:4692-700; PMID:16621189; http://dx.doi.org/10.1016/j.vaccine.2006.03.034
   PubMed Web of Science ®Google Scholar
• Terranella A, Cohn A, Clark T. Meningococcal conjugate vaccines: optimizing global impact. Infect Drug Resist 2011; 4:161-9; PMID:22114508; http://dx.doi.org/10.2147/IDR.S21545
   PubMedGoogle Scholar
• Pace D, Snape M, Westcar S, Hamaluba M, Yu LM, Begg N, Wysocki J, Czajka H, Maechler G, Boutriau D, et al. A new combination Haemophilus influenzae type B and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine for primary immunization of infants. Pediatr Infect Dis J 2007; 26:1057-9; PMID:17984816; http://dx.doi.org/10.1097/INF.0b013e31813429fa
   PubMed Web of Science ®Google Scholar
• Vesikari T, Esposito S, Prymula R, Ypma E, Kohl I, Toneatto D, Dull P, Kimura A. EU Meningococcal B Infant Vaccine Study group. Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials. Lancet 2013; 381:825-35; PMID:23324563; http://dx.doi.org/10.1016/S0140-6736(12)61961-8
   PubMed Web of Science ®Google Scholar
• Gossger N, Snape MD, Yu LM, Finn A, Bona G, Esposito S, Principi N, Diez-Domingo J, Sokal E, Becker B, et al; European MenB Vaccine Study Group. Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial. JAMA 2012; 307:573-82; PMID:22318278; http://dx.doi.org/10.1001/jama.2012.85
   PubMed Web of Science ®Google Scholar
• Frosi G, Biolchi A, Lo Sapio M, Rigat F, Gilchrist S, Lucidarme J, Findlow J, Borrow R, Pizza M, Giuliani MM, et al. Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage. Vaccine 2013; 31:4968-74; PMID:23954380; http://dx.doi.org/10.1016/j.vaccine.2013.08.006
   PubMed Web of Science ®Google Scholar
• Laribiere A, Miremont-Salame G, Reyre H, Abouelfath A, Liège L, Moore N, Haramburu F. Surveillance of adverse effects during a vaccination campaign against meningitis C. Eur J Clin Pharmacol 2005; 61:907-11; PMID:16328316; http://dx.doi.org/10.1007/s00228-005-0053-3
   PubMed Web of Science ®Google Scholar
• Anonymous. Global advisory committee on vaccine safety, 1-2 December 2005. Weekly Epidemiological Record 2006; 81:15-9; PMID:16671243
   PubMedGoogle Scholar
• Agrawal A, Murphy TF. Haemophilus influenza infections in the H. influenzae type b conjugate vaccine era. J Clin Microbiol 2011; 49:3728-32; PMID:21900515; http://dx.doi.org/10.1128/JCM.05476-11
   PubMed Web of Science ®Google Scholar
• Murphy TF, Faden H, Bakaletz LO, Kyd JM, Forsgren A, Campos J, Virji M, Pelton SI. Nontypeable Haemophilus influenzae as a pathogen in children. Pediatr Infect Dis J 2009; 28:43-8; PMID:19057458; http://dx.doi.org/10.1097/INF.0b013e318184dba2
   PubMed Web of Science ®Google Scholar
• Rao VK, Krasan GP, Hendrixson DR, Dawid S, St Geme JW 3rd. Molecular determinants of the pathogenesis of disease due to non-typeable Haemophilus influenzae. FEMS Microbiol Rev 1999; 23:99-129; PMID:10234841; http://dx.doi.org/10.1111/j.1574-6976.1999.tb00393.x
   PubMed Web of Science ®Google Scholar
• Wenger JD, Hightower AW, Facklam RR, Gaventa S, Broome CV. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. J Infect Dis 1990; 162:1316-23; PMID:2230261; http://dx.doi.org/10.1093/infdis/162.6.1316
   PubMed Web of Science ®Google Scholar
• Broome CV. Epidemiology of Haemophilus influenzae type b infections in the United States. Pediatr Infect Dis J 1987; 6:779-82
   PubMed Web of Science ®Google Scholar
• Yeh YH, Chu PH, Yeh CH, Wu YJ, Lee MH, Jung SM, Kuo CT. Haemophilus influenzae pericarditis with tamponade as the initial presentation of systemic lupus erythematosus. Int J Clin Pract. 2004; 58:1045-7; PMID:3313240; PMID:15605669; http://dx.doi.org/10.1111/j.1742-1241.2004.00041.x
   PubMed Web of Science ®Google Scholar
• Charuvanij S, Houghton KM. Acute epiglottitis as the initial presentation of pediatric Systemic Lupus Erythematosus. Pediatr Rheumatol Online J 2009; 7:19; PMID:19878586; http://dx.doi.org/10.1186/1546-0096-7-19
   PubMed Web of Science ®Google Scholar
• Robinson AB, DeWitt EM, Schanberg LE, Moody MA. Necrotizing fasciitis caused by Haemophilus influenzae type E in a 17-year-old girl with systemic lupus erythematosus. J Clin Rheumatol. 2010;16:49-50; PMID:20051761; http://dx.doi.org/10.1097/RHU.0b013e3181c7e095
   PubMed Web of Science ®Google Scholar
• Kuchar E, Miśkiewicz K, Karlikowska M. A review of guidance on immunization in persons with defective or deficient splenic function. Br J Haematol 2015; 171(5):683-94; PMID:26315210
   PubMed Web of Science ®Google Scholar
• Chandran A, Watt JP, Santosham M. Prevention of Haemophilus influenzae type b disease: past success and future challenges. Expert Rev Vaccines 2005; 4:819-27; PMID:16372878; http://dx.doi.org/10.1586/14760584.4.6.819
   PubMed Web of Science ®Google Scholar
• Decker MD, Edwards KM. Haemophilus influenzae type b vaccines: history, choice and comparisons. Pediatr Infect Dis J 1998; 17:113-6; http://dx.doi.org/10.1097/00006454-199809001-00004
   PubMed Web of Science ®Google Scholar
• Swingler G, Fransman D, Hussey G. Conjugate vaccines for preventing Haemophilus influenzae type B infections. Cochrane Database Syst Rev 2007; 2; 001729
   Google Scholar
• Borrow R, Balmer P, Roper MH. The Immunological Basis for Immunization Series–Module 3: Tetanus Update 2006. Geneva: World Health Organization 2007
   Google Scholar
• Broder KR, Cortese MM, Iskander JK, Kretsinger K, Slade BA, Brown KH, Mijalski CM, Tiwari T, Weston EJ, Cohn AC, Srivastava PU, Moran JS, Schwartz B, Murphy TV; Advisory Committee on Immunization Practices (ACIP). Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006; 55(RR-3):1-34.
   Google Scholar
• Kashef S, Ghazizadeh F, Derakhshan A, Farjadian S, Alyasin S. Antigen-specific antibody response in juvenile-onset SLE patients following routine immunization with tetanus toxoid. Iran J Immunol 2008; 5:181-4; PMID:18791286
   PubMedGoogle Scholar
• Devey ME, Bleasdale K, Isenberg DA. Antibody affinity and IgG subclass of responses to tetanus toxoid in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Immunol 1987; 68:562-9
   PubMed Web of Science ®Google Scholar
• Abe T, Homma M. Immunological reactivity in patients with systemic lupus erythematosus. Humoral antibody and cellular immune responses. Acta Rheumatol Scand 1971; 17:35-46; PMID:5546993; http://dx.doi.org/10.3109/rhe1.1971.17.issue-1-4.06
   PubMedGoogle Scholar
• Kashef S, Ghazizadeh F, Derakhshan A, Farjadian S, Alyasin S. Antigen-specific antibody response in juvenile-onset SLE patients following routine immunization with tetanus toxoid. Iran J Immunol 2008; 5:181-4
   PubMedGoogle Scholar
• Csuka D, Czirják L, Hóbor R, Illes Z, Bánáti M, Rajczy K, Tordai A, Füst G. Effective humoral immunity against diphtheria and tetanus in patients with systemic lupus erythematosus or myasthenia gravis. Mol Immunol 2013; 54:453-6; PMID:23454161; http://dx.doi.org/10.1016/j.molimm.2013.01.012
   PubMed Web of Science ®Google Scholar
• Diphtheria. WHO, Regional Office for the Western Pacific. http://www.wpro.who.int/health_topics/diphtheria/. Accessed 12/16/2009
   Google Scholar
• World Health Organization. Pertussis vaccines: WHO position paper—recommendations. Vaccine 2011; 29:2355-6; PMID:21129396; http://dx.doi.org/10.1016/j.vaccine.2010.11.059
   PubMed Web of Science ®Google Scholar
• CDC. Pertussis vaccination: acellular pertussis vaccine for the fourth and fifth doses of the DTP series. Update to supplementary ACIP Statement. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1992; 41:1-5; (No:RR-15)
   Google Scholar
• CDC. Pertussis vaccination: acellular pertussis vaccine for reinforcing and booster use—supplementary ACIP statement. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1992; 41:1-10; (No. RR-1)
   Google Scholar
• Kostinov MP, Tarasova AA, Zaĭtsev EM. Contents of antibodies to Bordetella pertussis antigens in patients with rheumatic diseases. Zh Mikrobiol Epidemiol Immunobiol 2007; 6:61-4
   PubMedGoogle Scholar
• Kiedrzynski T, Bissielo A, Suryaprakash M, Bandaranayake D. Whooping cough—where are we now? A review. N Z Med J 2015; 128:21-7; PMID:26117672
   PubMed Web of Science ®Google Scholar
• Murdaca G, Span∫ F, Contatore M, Guastalla A, Magnani O, Puppo F. Efficacy and safety of etanercept in chronic immune-mediated disease. Expert Opin Drug Saf 2014; 13:649-61; PMID:24654562; http://dx.doi.org/10.1517/14740338.2014.899579
   PubMed Web of Science ®Google Scholar
• Murdaca G, Orsi A, Span∫ F, Puppo F, Durando P, Icardi G, Ansaldi F. Influenza and pneumococcal vaccinations of patients with systemic lupus erythematosus: current views upon safety and immunogenicity. Autoimmun Rev 2014; 13:75-84; PMID:24044940; http://dx.doi.org/10.1016/j.autrev.2013.07.007
   PubMed Web of Science ®Google Scholar
• Cox NJ, Subbarao K. Influenza. Lancet 1999; 354:1277-82; PMID:10520648; http://dx.doi.org/10.1016/S0140-6736(99)01241-6
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Swine influenza A (A/H1N1) infection in two children—Southern California, March–April 2009. MMWR Morb Mortal Wkly Rep 2009; 58:400-4002; PMID:19390508
   PubMedGoogle Scholar
• Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V, et al. Antigenic and genetic characteristics of swine-origin 2009 A(A/H1N1) influenza viruses circulating in humans. Science 2009; 325:197-201; PMID:19465683; http://dx.doi.org/10.1126/science.1176225
   PubMed Web of Science ®Google Scholar
• Arom-Maor A, Shoenfeld Y. Vaccination and systemic lupus erythematosus: the bidirectional dilemmas. Lupus 2001; 10:237-40; PMID:11315360; http://dx.doi.org/10.1191/096120301673085478
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)–United States, 2012-13 influenza season. MMWR Morb Mortal Wkly Rep 2012; 61:613-8; PMID:22895385
   PubMedGoogle Scholar
• Food and Drug Administration. Summary minutes: Vaccines and Related Biological Products Advisory Committee, February 28-9, 2012. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2012. Available at http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/bloodvaccinesandotherbiologics/vaccinesandrelatedbiologicalproductsadvisorycommittee/ucm296193.pdf
   Google Scholar
• Williams GW, Steinberg AD, Reinertsen JL, Klassen LW, Decker JL, Dolin R. Influenza immunization in systemic lupus erythematosus. A double-blind trial. Ann Intern Med 1978; 88:729-34; PMID:352210; http://dx.doi.org/10.7326/0003-4819-88-6-729
   PubMed Web of Science ®Google Scholar
• Ristow SC, Gouglas G, Condemi JJ. Influenza vaccination of patients with systemic lupus erythematosus. Ann Intern Med 1978; 88:786-9; PMID:666135; http://dx.doi.org/10.7326/0003-4819-88-6-786
   PubMed Web of Science ®Google Scholar
• Abu-Shakra M, Press J, Varsano N, Levy V, Mendelson E, Sukenik S, Buskila D. Specific antibody response after influenza immunization in systemic lupus erythematosus. J Rheumatol 2002; 29:2555-7; PMID:12465151
   PubMed Web of Science ®Google Scholar
• Del Porto F, Lagana B, Biselli R, Donatelli I, Campitelli L, Nisini R, Cardelli P, Rossi F, D'Amelio R. Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity. Vaccine 2006; 24:3217-23; PMID:16466833; http://dx.doi.org/10.1016/j.vaccine.2006.01.028
   PubMed Web of Science ®Google Scholar
• Holvast A, van Assen S, de Haan A, Huckriede A, Benne CA, Westra J, Palache A, Wilschut J, Kallenberg CG, Bijl M. Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study. Rheumatology (Oxford) 2009; 48:1294-9; PMID:19692457; http://dx.doi.org/10.1093/rheumatology/kep200
   PubMed Web of Science ®Google Scholar
• Holvast B, Huckriede A, Kallenberg CG, Bijl M. Influenza vaccination in systemic lupus erythematosus: safe and protective? Autoimmun Rev 2007; 6:300-5; PMID:17412302; http://dx.doi.org/10.1016/j.autrev.2006.09.012
   PubMed Web of Science ®Google Scholar
• Lu CC, Wang YC, Lai JH, Lee TS, LIN HT, Chang DM. A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity Vaccine 2011; 29:444-50; PMID:21078406; http://dx.doi.org/10.1016/j.vaccine.2010.10.081
   PubMed Web of Science ®Google Scholar
• Holvast A, Huckriede A, Wilschut J, Horst G, De Vries JJ, Benne CA, Kallenberg CG, Bijl M. Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease. Ann Rheum Dis 2006; 65:913-8; PMID:16322083; http://dx.doi.org/10.1136/ard.2005.043943
   PubMed Web of Science ®Google Scholar
• Mercado U, Acosta H, Avendano L. Influenza vaccination of patients with systemic lupus erythematosus. Rev Invest Clin 2004; 56:16-20; PMID:15144037
   PubMedGoogle Scholar
• Stojanovich L. Influenza vaccination of patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Clin Dev Immunol 2006; 13:373-5; PMID:17162380; http://dx.doi.org/10.1080/17402520600800820
   PubMedGoogle Scholar
• Saad CG, Borba EF, Aikawa NE, Silva CA, Pereira RM, Calich AL, Moraes JC, Ribeiro AC, Viana VS, Pasoto SG, et al. Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases. Ann Rheum Dis 2011; 70:1068-73; PMID:21540203; http://dx.doi.org/10.1136/ard.2011.150250
   PubMed Web of Science ®Google Scholar
• Agmon-Levin N, Paz Z, Israeli E, Shoenfeld Y. Vaccines and autoimmunity. Nat Rev Rheumatol 2009; 5:648652; http://dx.doi.org/10.1038/nrrheum.2009.196
   Web of Science ®Google Scholar
• Shoenfeld Y, Agmon-Levin N. ‘ASIA’–autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun 2011; 36:4-8; PMID:20708902; http://dx.doi.org/10.1016/j.jaut.2010.07.003
   PubMed Web of Science ®Google Scholar
• Agmon-Levin N, Hughes GRV, Shoenfeld Y. The spectrum of ASIA: ‘Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants’. Lupus 2012; 21:118-20; http://dx.doi.org/10.1177/0961203311429316
   PubMed Web of Science ®Google Scholar
• Jara LJ, Medina G, Gómez-Bañuelos E, Saavedra MA, Vera-Lastra O. Still's disease, lupus-like syndrome, and silicone breast implants. A case of ‘ASIA’ (Shoenfeld's syndrome). Lupus 2012; 21:140-5; PMID:22235044; http://dx.doi.org/10.1177/0961203311430970
   PubMed Web of Science ®Google Scholar
• Zafrir Y, Agmon-Levin N, Paz Z, Shilton T, Shoenfeld Y. Autoimmunity following Hepatitis B vaccine as part of the spectrum of ‘Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants’ (ASIA): analysis of 93 cases. Lupus 2012; 21:146-52http://dx.doi.org/10.1177/0961203311429318
   PubMed Web of Science ®Google Scholar
• Bassi N, Luisetto R, Del Prete D, Ghirardello A, Ceol M, Rizzo S, Iaccarino L, Gatto M, Valente ML, Punzi L, et al. Induction of the ‘ASIA’ syndrome in NZB/NZWF1 mice after injection of complete Freund's adjuvant (CFA). Lupus 2012; 21:203-9; http://dx.doi.org/10.1177/0961203311429553
   PubMed Web of Science ®Google Scholar
• Nathanson N, Kew OM. From emergence to eradication: the epidemiology of poliomyelitis deconstructed. Am J Epidemiol 2010; 172:1213-29; PMID:20978089; http://dx.doi.org/10.1093/aje/kwq320
   PubMed Web of Science ®Google Scholar
• Schattner A, Ben-Chetrit E, Schmilovitz H. Poliovaccines and the course of systemic lupus erythematosus–a retrospective study of 73 patients. Vaccine 1992; 10:98-100; PMID:1539468; http://dx.doi.org/10.1016/0264-410X(92)90024-E
   PubMed Web of Science ®Google Scholar
• World Health Organization. Hepatitis B vaccines. Weekly Epidemiological Rec 2004; 79:255-63
   PubMedGoogle Scholar
• Maillefert JF, Sibilia J, Toussirot E, Vignon E, Eschard JP, Lorcerie B, Juvin R, Parchin-Geneste N, Piroth C, Wendling D, et al. Rheumatic disorders developed after hepatitis B vaccination. Rheumatology 1999; 38:978-83; PMID:10534549; http://dx.doi.org/10.1093/rheumatology/38.10.978
   PubMed Web of Science ®Google Scholar
• Maillefert JF, Tavernier C, Sibilia J,Vignon E. Exacerbation of systemic lupus erythematosus after hepatitis B vaccination: comment on the article by Battafarano et al. and the letter by Senecal et al. Arthritis Rheum 2000; 43:468-9; PMID:10693893; http://dx.doi.org/10.1002/1529-0131(200002)43:2%3c468::AID-ANR32%3e3.0.CO;2-K
   PubMed Web of Science ®Google Scholar
• Blank M1, Israeli E, Shoenfeld Y. When APS (Hughes syndrome) met the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) Lupus 2012; 21:711-4; PMID:22635209; http://dx.doi.org/10.1177/0961203312438115
   PubMed Web of Science ®Google Scholar
• Kuruma KA, Borba EF, Lopes MH, de Carvalho JF, Bonfá E. Safety and efficacy of hepatitis B vaccine in systemic lupus erythematosus. Lupus 2007; 16:350-4; PMID:17576737; http://dx.doi.org/10.1177/0961203307078225
   PubMed Web of Science ®Google Scholar
• Innis BL, Snitbhan R, Kunasol P, Laorakpongse T, Poopatanakool W, Kozik CA, Suntayakorn S, Suknuntapong T, Safary A, Tang DB, et al. Protection against hepatitis A by an inactivated vaccine. JAMA 1994; 271:1328-34; PMID:8158817; http://dx.doi.org/10.1001/jama.1994.03510410040030
   PubMed Web of Science ®Google Scholar
• Werzberger A, Mensch B, Kuter B, Brown L, Lewis J, Sitrin R, Miller W, Shouval D, Wiens B, Calandra G, et al. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N Engl J Med 1992; 327:453-7; PMID:1320740; http://dx.doi.org/10.1056/NEJM199208133270702
   PubMed Web of Science ®Google Scholar
• Pérez OM, Herzog C, Zellmeyer M, Loáisiga A, Frösner G, Egger M. Efficacy of virosome hepatitis A vaccine in young children in Nicaragua: randomized placebo-controlled trial. J Infect Dis 2003; 188:671-7; http://dx.doi.org/10.1086/377309
   PubMed Web of Science ®Google Scholar
• Zard E, Arnaud L, Mathian A, Chakhtoura Z, Hie M, Touraine P, Heard I, Amoura Z. Increased risk of high grade cervical squamous intraepithelial lesions in systemic lupus erythematosus: A meta-analysis of the literature. Auto Immune Rev 2014; 13:730-5; http://dx.doi.org/10.1016/j.autrev.2014.03.001
   PubMed Web of Science ®Google Scholar
• Lube G, Aikawa NE, Tacla M, Leal MM, Lourenço B, Silva LE, Queiroz LB, Baracat EC, Silva CA. Condyloma acuminatum by human papilloma virus infection in childhood-systemic lupus erythematosus patients. Acta Reumatol Port 2014; 39:182-7; PMID:25111418
   PubMed Web of Science ®Google Scholar
• Soybilgic A, Onel KB, Utset T, Alexander K, Wagner-Weiner L. Safety and immunogenicity of the quadrivalent HPV vaccine in female Systemic Lupus Erythematosus patients aged 12 to 26 years. Pediatr Rheumatol Online J 2013; 11:29; PMID:23924237; http://dx.doi.org/10.1186/1546-0096-11-29
   PubMed Web of Science ®Google Scholar
• Verstraeten T, Descamps D, David MP, Zahaf T, Hardt K, Izurieta P, Dubin G, Breuer T. Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines. Vaccine 2008; 26:6630-8; PMID:18845199; http://dx.doi.org/10.1016/j.vaccine.2008.09.049
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. MMRV clinical review. Available at http://www.fda.gov/downloads/BiologicsBloodVaccines/vaccines/Approved/Products/ucm123800
   Google Scholar
• CDC. General recommendations on immunization—recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2011; 60:1-64; (No. RR-2)
   Google Scholar
• Groot N, Heijstek MW, Wulffraat NM. EULAR recommendations for vaccination in pediatric patients with rheumatic diseases Ann Rheum Dis 2011; 70:1704-12 originally published online August 3, 2011; PMID:21813547; http://dx.doi.org/10.1136/ard.2011.150193
   PubMed Web of Science ®Google Scholar
• Miyamoto M, Ono E, Barbosa C, Terreri M, Hilário M, Salomão R, de Moraes-Pinto M. Vaccine antibodies and T- and B-cell interaction in juvenile systemic lupus erythematosus. Lupus 2011; 20:736-44; PMID:21505013; http://dx.doi.org/10.1177/0961203310397409
   PubMed Web of Science ®Google Scholar
• Kang I1, Park SH. Infectious complications in SLE after immunosuppressive therapies. Curr Opin Rheumatol 2003; 15:528-34; PMID:12960476; http://dx.doi.org/10.1097/00002281-200309000-00002
   PubMed Web of Science ®Google Scholar
• Chakravarty EF, Michaud K, Katz R, Wolfe F. Increased incidence of herpes zoster among patients with systemic lupus erythematosus. Lupus 2013; 22:238-44; PMID:23257402; http://dx.doi.org/10.1177/0961203312470186
   PubMed Web of Science ®Google Scholar
• Guthridge JM, Cogman A, Merrill JT, Macwana S, Bean KM, Powe T, Roberts V, James JA, Chakravarty EF. Herpes zoster vaccination in SLE: a pilot study of immunogenicity. J Rheumatol 2013; 40:1875-80; PMID:24037550; http://dx.doi.org/10.3899/jrheum.130170
   PubMed Web of Science ®Google Scholar